Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001957799-24-000270
Filing Date
2024-10-16
Accepted
2024-10-16 17:17:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 6724
  Complete submission text file 0001957799-24-000270.txt   8387
Mailing Address 1134 KLINE STREET LA JOLLA CA 92037
Business Address 1134 KLINE STREET LA JOLLA CA 92037 8583482180
Avalon Ventures XI, L.P. (Reporting) CIK: 0001652901 (see all company filings)

EIN.: 474748883 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144

Mailing Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130
Business Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130 (858) 751-4493
Janux Therapeutics, Inc. (Subject) CIK: 0001817713 (see all company filings)

EIN.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40475 | Film No.: 241375376
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)